MBX
MBX Biosciences
MBX
MBX
87 hedge funds and large institutions have $420M invested in MBX Biosciences in 2025 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 40 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
10% more funds holding
Funds holding: 79 → 87 (+8)
3.5% more ownership
Funds ownership: 106.72% → 110.22% (+3.5%)
48% less call options, than puts
Call options by funds: $848K | Put options by funds: $1.63M
Holders
87
Holding in Top 10
3
Calls
$848K
Puts
$1.63M
Top Buyers
| 1 | +$9.85M | |
| 2 | +$6.8M | |
| 3 | +$6.2M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$4.92M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.31M |
Top Sellers
| 1 | -$12.9M | |
| 2 | -$9.47M | |
| 3 | -$4.24M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$2.2M |
| 5 |
AAA
Affinity Asset Advisors
New York
|
-$1.29M |
